Cardiology Updates by Xagena

CardiologyOnline.net :: Cardiology

Cardiology Online, Cardiology Xagena, Cardiology Newsletter, Cardiology News, Updates in cardiology, Aggiornamento in Medicina, Cardiovascular Drugs :: Updates, Cancer Drugs :: Updates,

Brilinta

Antiplatelet agents: Brilinta first to show reduction in …

Clinical outcomes according to …

Clinical outcomes according to QRS duration and morphology …

Cordarone

Atrial fibrillation: Betapace less effient than Cordarone for …

Lower dose beta-blocker …

Lower dose beta-blocker therapy is … therapy will be associated …

Crestor

Crestor may reverse atherosclerosis in patients with …

Angiox

Myocardial infarction: Heparin rather than Bivalirudin after …

Angiomax

Angiomax alone reduces a significant number of major …

Acute myocardial infarction …

Acute myocardial infarction: Cyclosporine, an …

Patients with ST-segment …

Patients with ST-segment elevation myocardial infarction …

Treatment of heart failure: the …

Treatment of heart failure: the path to Entresto, an … to an …

Cancer Therapy Updates by Xagena

Oncology :: OncologyOnline.net 

OncologyOnline.net, News Oncology, Oncology Updates, The Frontier in Cancer Therapy, Newsletter Medicine, Aggiornamento in Medicina oncologica, Cancer Drugs Updates,

Advanced, metastatic non …

Advanced, metastatic non-small-cell lung cancer: Afatinib in TKI …

Crizotinib superior to standard …

Crizotinib superior to standard first-line Pemetrexed-plus-Platinum …

Nivolumab, antitumor activity …

Nivolumab, antitumor activity with a manageable safety profile in …

Pembrolizumab for advanced …

Pembrolizumab for advanced urothelial cancer: updated …

Cancer immunotherapy …

Cancer immunotherapy: Atezolizumab has …

Vismodegib for treatment of …

Vismodegib for treatment of basal cell … with metastatic basal cell …

Metastatic renal cell carcinoma …

Metastatic renal cell carcinoma: Nivolumab has demonstrated …

Non-small cell lung cancer …

Non-small cell lung cancer harboring wild-type EGFR …

ASCO clinical practice …

ASCO clinical practice guideline: systemic therapy for stage IV …

Patients with metastatic or …

Patients with metastatic or unresectable urothelial cancer …